LivaNova's third quarter included top-line growth of 10% in constant currency and adjusted operating income up 15% year over year. Management raised the full-year outlook for both cardiopulmonary and neuromodulation growth by 100 basis points at the midpoint, for total sales growth of 9% to 10%.
LivaNova continues to enjoy a large footprint in the heart-lung machine market, which comes with the sale of consumable oxygenators.
We think LivaNova has less bandwidth or infrastructure than larger competitors to integrate and optimize innovation following the acquisition of new technology.
Metric | LIVN | GETI B | MDT |
|---|---|---|---|
Price/Earnings (Normalized) | 21.65 | 22.87 | 17.95 |
Price/Book Value | 3.66 | 2.26 | 2.59 |
Price/Sales | 3.38 | 2.14 | 3.48 |
Price/Cash Flow | 16.52 | 13.93 | 14.58 |
Metric | LIVN | GETI B | MDT |
|---|---|---|---|
Quick Ratio | 1.14 | 0.72 | 1.29 |
Current Ratio | 1.46 | 1.25 | 2.07 |
Interest Coverage | 4.31 | 7.91 | 10.12 |
Metric | LIVN | GETI B | MDT |
|---|---|---|---|
Return on Assets (Normalized) | 9.36% | 6.11% | 8.31% |
Return on Equity (Normalized) | 19.46% | 11.50% | 15.59% |
Return on Invested Capital (Normalized) | 15.53% | 9.40% | 10.57% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|!H#sGZ | LOCK|%<n>B | $191B | |||
| Medtronic PLC MDT | LOCK|F&sGsJj | LOCK|@zQQ | $130B | |||
| Stryker Corp SYK | LOCK|LMrSkSl | LOCK|Zc | $123B | |||
| Boston Scientific Corp BSX | LOCK|?m&$&m | LOCK|QwJ! | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|XBMV@l$ | LOCK|&Q#d | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|?l?YCJ# | LOCK|<H | $38B | |||
| DexCom Inc DXCM | LOCK|#$By!@fL | LOCK|sPl!< | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|!$ | LOCK|F$X | $30B | |||
| Steris PLC STE | LOCK|Y%$h#$ | LOCK|^Jz$T | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|Q&@$P#B | LOCK|%pM | $20B |
United States